Get the full picture
Sign in to uncover key details.
Elixirgen Therapeutics
Business Services · Maryland, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
855 N Wolfe St Ste 62, Baltimore, Maryla...Phone Number
(443) 869-5420Revenue
$5.3 MillionIndustry
About Elixirgen Therapeutics
Ricoh Biosciences specializes in iPSC technology for drug discovery and disease modeling, offering a range of iPSC-derived cells and differentiation kits. Their services include custom iPSC differentiation, novel cell type development, and disease modeling, aimed at accelerating research and therapeutic development. The company targets clients in the biotech and pharmaceutical sectors, providing scalable and functional human cell models for various applications. With a commitment to transforming drug development decisions, Ricoh Biosciences supports researchers with educational resources and partnership opportunities.Explore more
Elixirgen Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Elixirgen Therapeutics
Compare insights from companies similar to Elixirgen Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Elixirgen Therapeutics Tech Stack
A closer look at the technologies used by Elixirgen Therapeutics
Top Business Services Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding Elixirgen Therapeutics
Sign Up For FreeTo access detailed company insights
Ricoh Biosciences specializes in iPSC technology for drug discovery and disease modeling, offering a range of iPSC-derived cells and differentiation kits. Their services include custom iPSC differentiation, novel cell type development, and disease modeling, aimed at accelerating research and therapeutic development. The company targets clients in t... Read More
